|
⚲
|
| Keyboard |
| Barrett M James
✚
|
|
|---|---|
| CIK # | 0001219855 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001219855] | |
| 4 | [0001219855] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Senseonics Holdings Inc SENS
Stock Option (right to buy) · derivative
|
2019-05-30 | Grant | 86,930 | $0.00 | |
|
Senseonics Holdings Inc SENS
Common Stock
|
2019-01-02 | Grant | 3,624 | $2.69 | 9,749 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 49,030 | $0.12 | 5,884 |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 49,030 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 3,279,627 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 181,190 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 1,800,000 | $5.00 | 9,000,000 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Sell | 1,177 | $5.00 | 5,885 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Sell | 4,349 | $5.00 | 21,745 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 4,841,634 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 181,190 | $0.12 | 21,743 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 437,706 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 1,124,301 | $0.00 | |
|
Clovis Oncology Inc CLVS
Stock Option (Right to Buy) · derivative
|
2018-10-11 | Grant | 14,770 | $0.00 | |
|
Senseonics Holdings Inc SENS
Common Stock
|
2018-10-01 | Grant | 2,147 | $4.54 | 9,747 |
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
|
2018-09-07 | Buy | 3,000,000 | $1.67 | 5,010,000 |
|
Liquidia Technologies Inc LQDA
Common Stock
|
2018-07-30 | Conversion | 515,547 | ||
|
Liquidia Technologies Inc LQDA
Warrant to purchase Series D Preferred Stock · derivative
|
2018-07-30 | Other | 684,911 | ||
|
Liquidia Technologies Inc LQDA
Series B Preferred Stock · derivative
|
2018-07-30 | Conversion | 3,645,307 | ||
|
Liquidia Technologies Inc LQDA
Common Stock
|
2018-07-30 | Buy | 545,455 | $11.00 | 6,000,005 |
| showing 20 of 200 most recent transactions | |||||